From: Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy
Species
CL (L/h/kg)
Vss (L/kg)
iv t1/2 (h)
AUC (μM h)
F (%)
t1/2 (h)
Rat
1.1
2.0
1.4
1.3
11
2.2
Dog
0.5
0.7
3.1
29
59
4.9
Cyno
0.8
1.8
3.3
9.3
33
2.7